Anzeige
Mehr »
Login
Mittwoch, 22.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die Wachstumsgeschichte: Analysten sehen kurzfristige +37 %-Chance bei diesem europäischen Marktführer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QEF3 | ISIN: CA98980M1095 | Ticker-Symbol:
NASDAQ
21.05.24
21:56 Uhr
0,178 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ZOMEDICA CORP Chart 1 Jahr
5-Tage-Chart
ZOMEDICA CORP 5-Tage-Chart

Aktuelle News zur ZOMEDICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiZomedica Corp.: Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024105ANN ARBOR, MI / ACCESSWIRE / May 21, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products...
► Artikel lesen
15.05.Zomedica Corp.: Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA Platform229OTA capability enhances introduction of new assays from rapidly expanding menuANN ARBOR, MI / ACCESSWIRE / May 15, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
► Artikel lesen
14.05.Zomedica And 3 Other Stocks Under $3 Insiders Are Buying1
10.05.Zomedica Corp. (ZOM) Q1 2024 Earnings Call Transcript1
09.05.Zomedica Corp.: Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity288Performance Sets New Record for First Quarter RevenueANN ARBOR, MI / ACCESSWIRE / May 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering...
► Artikel lesen
09.05.Zomedica Corp. - 8-K, Current Report2
09.05.Zomedica Corp. - 10-Q, Quarterly Report2
08.05.Zomedica Corp.: Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024459ANN ARBOR, MI / ACCESSWIRE / May 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for...
► Artikel lesen
06.05.Zomedica Corp.: Zomedica Expands International Reach with CE Certification for VetGuardian System238Key approval paves way for European expansion, tapping into a $4 billion vet services market ANN ARBOR, MI / ACCESSWIRE / May 6, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company")...
► Artikel lesen
02.05.Zomedica Corp.: Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA Diagnostic Platform276Intellectual property portfolio now includes 188 Patents and 131 Trademarks providing robust protection for the Company's product platforms ANN ARBOR, MI / ACCESSWIRE / May 2, 2024 / Zomedica Corp....
► Artikel lesen
30.04.Zomedica Corp.: Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET192ANN ARBOR, MI / ACCESSWIRE / April 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products...
► Artikel lesen
09.04.Zomedica Corp.: Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024266ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products...
► Artikel lesen
04.04.Zomedica Corp. - 8-K, Current Report1
02.04.Zomedica Corp. (ZOM) Q4 2023 Earnings Call Transcript2
02.04.Earnings call: Zomedica reports record revenues and strategic growth1
01.04.Zomedica reports Q4 results2
01.04.Zomedica Corp.: Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity220ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products...
► Artikel lesen
01.04.Zomedica Corp. - 10-K, Annual Report1
20.03.Zomedica Corp.: Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET603ANN ARBOR, MI / ACCESSWIRE / March 20, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products...
► Artikel lesen
15.03.Zomedica Corp. - 8-K, Current Report-
Seite:  Weiter >>
54 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1